Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2019 Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 325, 2019.
   Google Scholar
• DecramerM, JanssensW. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1:73–83. doi:10.1016/S2213-2600(12)70060-724321806
   PubMed Web of Science ®Google Scholar
• VanfleterenL, SpruitMA, WoutersEFM, FranssenFME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016;4:911–924. doi:10.1016/S2213-2600(16)00097-727264777
   PubMed Web of Science ®Google Scholar
• ChubachiS, SatoM, KameyamaN, et al; Keio COPD Combordity Research (K-CCR) group. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort. Respir Med. 2016;117:272–279. doi:10.1016/j.rmed.2016.07.00227492541
   PubMed Web of Science ®Google Scholar
• IrieH, ChubachiS, SatoM, et al. Impact of cataract on health-related quality of life in a longitudinal Japanese chronic obstructive pulmonary cohort. Chron Respir Dis. 2018;15:329–338. doi:10.1177/147997231774573529232989
   PubMed Web of Science ®Google Scholar
• ChubachiS, TakahashiS, TsutsumiA, et al. Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:1613–1624. doi:10.2147/COPD28615934
   PubMed Web of Science ®Google Scholar
• ChubachiS, NakamuraH, SasakiM, et al; Keio COPD Combordity Research(K-CCR) Group. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD. Respirology. 2015;20:286–295. doi:10.1111/resp.1242925392953
   PubMed Web of Science ®Google Scholar
• ChaouatA, NaeijeR, WeitzenblumE. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–1385. doi:10.1183/09031936.0001560818978137
   PubMed Web of Science ®Google Scholar
• KesslerR, FallerM, FourgautG, MennecierB, WeitzenblumE. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:158–164. doi:10.1164/ajrccm.159.1.98031179872834
   PubMed Web of Science ®Google Scholar
• SimsMW, MargolisDJ, LocalioAR, PanettieriRA, KawutSM, ChristieJD. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest. 2009;136:412–419. doi:10.1378/chest.08-273919318664
   PubMed Web of Science ®Google Scholar
• Oswald-MammosserM, WeitzenblumE, QuoixE, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193–1198. doi:10.1378/chest.107.5.11937750305
   PubMed Web of Science ®Google Scholar
• HoeperMM, BogaardHJ, CondliffeR, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42–D50. doi:10.1016/j.jacc.2013.10.03224355641
   PubMed Web of Science ®Google Scholar
• MinaiOA, FesslerH, StollerJK, et al; NETT Research Group. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema. Respir Med. 2014;108:482–490. doi:10.1016/j.rmed.2013.11.00624290900
   PubMed Web of Science ®Google Scholar
• CutticaMJ, KalhanR, ShlobinOA, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–1882. doi:10.1016/j.rmed.2010.05.00920547449
   PubMed Web of Science ®Google Scholar
• GalieN, HumbertM, VachieryJL, et al; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 37;2016:67–119. doi:10.1093/eurheartj/ehv31726320113
   PubMed Web of Science ®Google Scholar
• CurriePJ, SewardJB, ChanKL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750–756. doi:10.1016/S0735-1097(85)80477-04031289
   PubMed Web of Science ®Google Scholar
• BergerM, HaimowitzA, Van ToshA, BerdoffRL, GoldbergE. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359–365. doi:10.1016/S0735-1097(85)80172-84019921
   PubMed Web of Science ®Google Scholar
• GartmanEJ, BlundinM, KlingerJR, YammineJ, RobertsMB, Dennis McCoolF. Initial risk assessment for pulmonary hypertension in patients with COPD. Lung. 2012;190:83–89. doi:10.1007/s00408-011-9346-822094960
   PubMed Web of Science ®Google Scholar
• ChenY, LiuC, LuW, et al. Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study. J Thorac Dis. 2016;8:350–358. doi:10.21037/jtd27076929
   PubMed Web of Science ®Google Scholar
• FayngershV, DrakopanagiotakisF, Dennis McCoolF, KlingerJR. Pulmonary hypertension in a stable community-based COPD population. Lung. 2011;189:377–382. doi:10.1007/s00408-011-9315-221814783
   PubMed Web of Science ®Google Scholar
• MiyazakiM, NakamuraH, ChubachiS, et al; Keio COPD Combordity Research(K-CCR)Group. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13. doi:10.1186/1465-9921-15-1324502760
   PubMed Web of Science ®Google Scholar
• SatoM, ChubachiS, SasakiM, et al. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Int J Chron Obstruct Pulmon Dis. 2016;11:1269–1278. doi:10.2147/COPD.S10545427354785
   PubMed Web of Science ®Google Scholar
• MillerMR, HankinsonJ, BrusascoV, et al. ATS/ERS task force, standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• KwonN, AminM, HuiDS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest. 2013;143:703–710. doi:10.1378/chest.12-053523460156
   PubMed Web of Science ®Google Scholar
• HajiroT, NishimuraK, TsukinoM, IkedaA, KoyamaH, IzumiT. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1185–1189. doi:10.1164/ajrccm.158.4.98020919769280
   PubMed Web of Science ®Google Scholar
• HajiroT, NishimuraK, TsukinoM, IkedaA, KoyamaH, IzumiT. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785–790. doi:10.1164/ajrccm.157.3.97030559517591
   PubMed Web of Science ®Google Scholar
• JonesPW, QuirkFH, BaveystockCM, LittlejohnsP. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327. doi:10.1164/ajrccm/145.6.13211595997
   PubMed Web of Science ®Google Scholar
• FukuharaS, BitoS, GreenJ, HsiaoA, KurokawaK. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998;51:1037–1044. doi:10.1016/S0895-4356(98)00095-X9817121
   PubMed Web of Science ®Google Scholar
• RudskiLG, LaiWW, AfilaloJ, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713; quiz 786–688. doi:10.1016/j.echo.2010.05.010
   PubMed Web of Science ®Google Scholar
• MishimaM, HiraiT, ItohH, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 1999;96:8829–8834. doi:10.1073/pnas.96.16.882910430855
   PubMed Web of Science ®Google Scholar
• NakanoY, MuroS, SakaiH, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162:1102–1108. doi:10.1164/ajrccm.162.3.990712010988137
   PubMed Web of Science ®Google Scholar
• WashkoGR, HunninghakeGM, FernandezIE, et al; COPD Gene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 364;2011:897–906. doi:10.1056/NEJMoa100728521388308
   PubMed Web of Science ®Google Scholar
• ChenX, LiuK, WangZ, et al. Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2015;10:2525–2533. doi:10.2147/COPD26604739
   PubMed Web of Science ®Google Scholar
• SpencerS, CalverleyPM, Sherwood BurgeP, JonesPW; ISOLDE Study Group Inhaled Steroids in Obstructive Lung Disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:122–128. doi:10.1164/ajrccm.163.1.200500911208636
   PubMed Web of Science ®Google Scholar
• KonSS, CanavanJL, JonesSE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2:195–203. doi:10.1016/S2213-2600(14)70001-324621681
   PubMed Web of Science ®Google Scholar
• de TorresJP, CasanovaC, HernándezC, AbreuJ, Aguirre-JaimeA, CelliBR. Gender and COPD in patients attending a pulmonary clinic. Chest. 2005;128:2012–2016. doi:10.1378/chest.128.4.201216236849
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, Martinez-GarciaMA, Román SánchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• AbrahamAS, ColeRB, GreenID, Hedworth-WhittyRB, ClarkeSW, BishopJM. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res. 1969;24:51–60. doi:10.1161/01.RES.24.1.515763739
   PubMed Web of Science ®Google Scholar
• PeinadoVI, GomezFP, BarberaJA, et al. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant. J Heart Lung Transplant. 2013;32(12):1262–1269. doi:10.1016/j.healun.2013.09.00724263025
   PubMed Web of Science ®Google Scholar
• KasaharaY, TuderRM, CoolCD, LynchDA, FloresSC, VoelkelNF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163:737–744. doi:10.1164/ajrccm.163.3.200211711254533
   PubMed Web of Science ®Google Scholar
• KasaharaY, TuderRM, Taraseviciene-StewartL, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106:1311–1319. doi:10.1172/JCI1025911104784
   PubMed Web of Science ®Google Scholar
• WeissmannN. Chronic obstructive pulmonary disease and pulmonary vascular disease. A comorbidity? Ann Am Thorac Soc. 2018;15(Suppl 4):S278–S281. doi:10.1513/AnnalsATS.201808-532MG30759003
   PubMed Web of Science ®Google Scholar
• SeimetzM, ParajuliN, PichlA, et al. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell. 2011;147(2):293–305. doi:10.1016/j.cell.2011.08.03522000010
   PubMed Web of Science ®Google Scholar
• PichlA, SommerN, BednorzM, et al. Riociguat for treatment of pulmonary hypertension in COPD: a translational study. Eur Respir J. 2019;53(6). doi:10.1183/13993003.02445-2018
   PubMed Web of Science ®Google Scholar
• CottinV, Le PavecJ, PrévotG, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35:105–111. doi:10.1183/09031936.0003870919643948
   PubMed Web of Science ®Google Scholar
• ChaouatA, BugnetAS, KadaouiN, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–194. doi:10.1164/rccm.200401-006OC15831842
   PubMed Web of Science ®Google Scholar
• ThabutG, DauriatG, SternJB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–1536. doi:10.1378/chest.127.5.153115888824
   PubMed Web of Science ®Google Scholar
• ChatterjeeK, TarawnehAR, AlamS. Out of proportion pulmonary hypertension in obstructive lung diseases. Curr Opin Pulm Med. 2018;24:161–172. doi:10.1097/MCP.000000000000045729256906
   PubMed Web of Science ®Google Scholar
• Levi-ValensiP, WeitzenblumE, RidaZ, et al. Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. Eur Respir J. 1992;5:301–307.1572442
   PubMed Web of Science ®Google Scholar
• BoysenPG, BlockAJ, WynneJW, HuntLA, FlickMR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest. 1979;76:536–542. doi:10.1378/chest.76.5.536498826
   PubMed Web of Science ®Google Scholar
• TimmsRM, KhajaFU, WilliamsGW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med. 1985;102:29–36. doi:10.7326/0003-4819-102-1-293966742
   PubMed Web of Science ®Google Scholar
• ArcasoySM, ChristieJD, FerrariVA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167:735–740. doi:10.1164/rccm.200210-1130OC12480614
   PubMed Web of Science ®Google Scholar
• Mohamed HoeseinFA, BesselinkT, PompeE, et al. Accuracy of CT pulmonary artery diameter for pulmonary hypertension in end-stage COPD. Lung. 2016;194(5):813–819. doi:10.1007/s00408-016-9926-827423782
   PubMed Web of Science ®Google Scholar
• HurdmanJ, CondliffeR, ElliotCA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41:1292–1301. doi:10.1183/09031936.0007951223018917
   PubMed Web of Science ®Google Scholar
• HaraguchiM, NakamuraH, SasakiM, Keio COPD combordity Research(K-CCR) Group, et al. Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients. BMC Res Notes. 9;2016:7. doi:10.1186/s13104-015-1810-826728686
   PubMedGoogle Scholar